Electro-Equiscope: Intelligent Bioimpedance Therapy for Pain Management and Functional Recovery in Horses and Humans

Abstract

Electro-Equiscope therapy is an advanced dynamic bioimpedance-guided microcurrent technology designed for pain management, functional rehabilitation, and inflammation reduction in both human and equine patients. Given the increasing demand for non-invasive, drug-free pain relief, this study evaluates the clinical efficacy of Electro-Equiscope therapy in improving pain scores, mobility, and quality of life outcomes. Methods: This observational study analyzed survey data regarding 58 respondents (38 human, 20 equine) who underwent Electro-Equiscope therapy. Pain levels were assessed pre- and post-treatment using a Likert scale ranging from 0 (no pain) to 6 (severe pain/lameness), and statistical significance was determined via paired t-tests and confidence interval (CI) analysis. Additional qualitative reports on functional improvement, mood, inflammation reduction, and unexpected outcomes were collected and analyzed. Results: Electro-Equiscope therapy resulted in a statistically significant reduction in pain scores (p < 0.00001, t = 11.56) across both human and equine groups. The mean pain level for humans decreased from 4.58 to 2.30, which is a 49.8% reduction. The mean lameness score for horses dropped from 4.35 to 1.45, which is a 66.7% reduction. Substantial long-term pain relief was reported (80% in horses, 60% in humans). Functional improvements were observed in 95% of both groups, including increased mobility, faster recovery, and enhanced daily function. Stress reduction was notable, with 82% of humans and 95% of horses experiencing decreased anxiety and tension. High satisfaction rates were reported, with 100% of horse owners and 92% of human participants recommending the therapy, with no adverse reports. Conclusion: The findings suggest that Electro-Equiscope therapy is a promising non-invasive modality for pain relief and functional recovery in both human and equine applications. The statistically significant improvements in pain reduction, mobility, and quality of life highlight its potential as an adjunctive pain management strategy. However, further standardized and randomized controlled trials (RCTs) are needed to validate its mechanisms, optimize treatment protocols, and establish long-term efficacy.